<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did P3 Health Partners' revenue and expenses trend in Q4 2024?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        5/8/2025 06:10pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">P3 Health Partners (PIII) experienced a significant revenue increase in Q4 2024, with total revenue reaching $370.69 million. However, the company also faced notable expenses, with total expenses amounting to $129.15 million for the quarter. The substantial revenue growth suggests a strong performance in generating income, despite the expenses, which indicates a healthy financial trend for the period.


|code|Ticker|Name|Date|Total Revenue|Total Expenses|Net Income|market_code|
|---|---|---|---|---|---|---|---|
|PIII|PIII.O|P3 Health Partners|2024 Q1|3.88488E8||-4.9606E7|186|
|PIII|PIII.O|P3 Health Partners|2024 Q2|3.79157E8||-2.8774E7|186|
|PIII|PIII.O|P3 Health Partners|2024 Q3|3.62124E8||-1.0285E8|186|
|PIII|PIII.O|P3 Health Partners|2024 Q4|3.70686E8||-1.29148E8|186|

</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw){return {layout:"default",data:[{noData:c,currentQuestion:g,textDescription:W,comeFrom:"AInvestShareLink",events:[],answerSource:o}],fetch:{},error:p,state:{sharePreviewModule:{loadJgySuccess:d,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:h,agent_id:a,output_media_info:[],task_id:a,language:a,source:o,cache_builder:a,reply_action:"Answer",execute_mode:H,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did P3 Health Partners' revenue and expenses trend in Q4 2024?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did P3 Health Partners' revenue and expenses trend in Q4 2024?\",\"user_id\":\"dp14838633\",\"user_name\":\"\",\"trace_id\":\"5681d10a-4d3e-404a-ad7c-6221ac6036b9\",\"session_id\":\"5681d10a-4d3e-404a-ad7c-6221ac6036b9\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:j,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|Total Revenue[20241231]|Total Expenses[20241231]|Net Income[20241231]|Report End Date|\n|---|---|---|---|---|---|---|---|\n|PIII|P3 Health Partners|$8.62|-1.82%|$370.69 million||-$129.15 million|20241231|\n",query_data:{number:h,title:I,query_type:j,condition:a,model_sql:X,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:d}}}],answer_chain_name:Y,agent_mode:Z,native_answer:a,come_from:a,text_answer:W,trace_id:i,cost:15765,event_names:a,question:g,fallback_type:_,input_type:$,fall_back_reason:{fall_back_type:_,may_fall_back_reason:"UNKNOWN",risk_detail:{matched_words:[]}},session_id:i,first_return_cost:2651,cache_type:"no_cache",question_id:i,transfer_question:g,signal_type:"ON_COMPLETE",start_time:J,remote_svc:o,slots:[],answer_type:H,user_id:z,skill_name:K},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:i,session_id:i,user_id:z,question:g,source:o,raw_question:g,version:"3.4.1",action_name:K,nlu:{entity:[{type:aa,value:q,market:k}]},output_time:J,deep_research:c,deep_thinking:c,agent_mode:Z},extra:{}},{answer_path:A,section:{id:B,info_texts:["Thinking"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:A,section:{id:B,info_texts:["Querying Stock: PIII Revenue, Expenses, Net Income in Q4 2024"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"thinking"},logs:[],extra:{action:"Querying Stock",action_input:I,thought:"The user seeks to analyze P3 Health Partners' Q4 2024 revenue and expense trends. I should focus on its Q4 2024 revenue, expense, and net income data. I will use FinQuery for the data mentioned above."}},{answer_path:e,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:A,section:{id:B,info_texts:["Generating Answer"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:e,section:{id:s,info_texts:[],show_type:D,voice_txt:"P",text_answer:ab,rich_text:ab,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:2000,info_texts:[],show_type:D,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:I,query_type:j,trace_data:a,index:h,model_sql:X,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:d},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:s,info_texts:[],show_type:D,voice_txt:".\n\n",text_answer:ac,rich_text:ac,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:t,market_id:k,name:m,domain:aa},pos:d,section_id:s,txt:m,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:s,info_texts:[],show_type:ad,choice:[],result_page:{components:[{uuid:"51860107bc0db731",config:{score:116,show_type:ae,scoreRuleNames:"value_unit;data_size;",showDataZoom:b,show_type_id:131,title:"分组柱状图",render:{x:u,y:[E,F]},title_config:{config:{display:b,display2:c,txt_style:d,url:a},data:{h1:af,h2:a},show_type:L}},data:{chunks_info:"[]",code_count:h,columns:[{index_name:M,key:M,label:"hq_code",source:N,type:f},{domain:v,feKey:O,index_name:O,key:O,label:M,origin_index:"stock code",source:N,type:f,unit:a},{domain:v,feKey:P,index_name:P,key:P,label:"name",origin_index:"stock name",source:N,type:f,unit:a},{feKey:u,index_name:u,key:u,label:"date",origin_index:u,type:"DATE"},{domain:v,feKey:E,index_name:E,key:E,label:a,source:a,timestamp:a,type:Q,unit:R},{domain:v,feKey:S,index_name:S,key:S,label:a,source:a,timestamp:a,type:Q,unit:R},{domain:v,feKey:F,index_name:F,key:F,label:a,source:a,timestamp:a,type:Q,unit:R},{index_name:ag,key:ag,type:f}],condition:"[{\"sonSize\":5,\"opName\":\"and\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@stock code\",\"indexProperties\":[\"EQUAL PIII.O\"],\"indexPropertiesMap\":{\"EQUAL\":\"PIII.O\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":3,\"opName\":\"or\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Total Expenses\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20241231\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20241231\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Net Income\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20241231\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20241231\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Total Revenue\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20241231\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20241231\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0}]",dataSize:4,datas:[{"Net Income":-49606000,code:t,"Total Revenue":388488000,Ticker:q,market_code:k,Date:"2024 Q1",Name:m},{"Net Income":-28774000,code:t,"Total Revenue":379157000,Ticker:q,market_code:k,Date:"2024 Q2",Name:m},{"Net Income":-102850000,code:t,"Total Revenue":362124000,Ticker:q,market_code:k,Date:"2024 Q3",Name:m},{"Net Income":-129148000,code:t,"Total Revenue":370686000,Ticker:q,market_code:k,Date:"2024 Q4",Name:m}],meta:{extra:{}},row_count:h,status_code:d,status_msg:"ok"},category:"generic",chart_type:"groupedBar",show_type:ae,title_config:{config:{display:b,display2:c,txt_style:d,url:a},data:{h1:af,h2:a},show_type:L},support_refresh:b,data_config:{query:a,query_type:j,data_ext_params:{}}}],global:{query_type:j},page:{language:a,layout:{layout_data:"[{\"children\":[],\"showType\":\"bar3\",\"uuid\":\"51860107bc0db731\"}]"},render_for:T},data_config:{query:a,query_type:j,data_ext_params:{}}},tag_info_list:[],is_last:c,uuid:"c4ff7e85-e7f9-4d6d-b2d9-923327e46619"},logs:[],extra:{}},{answer_path:e,section:{id:s,info_texts:[],show_type:D,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:A,section:{id:B,info_texts:["Completed"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:ad,choice:[{display_text:w,query_text:w,trace_info:{item_id:"00bd65451ab48cbe683de371aa214ee7",item_type:n,item_name:w,rec_info:ah}},{display_text:x,query_text:x,trace_info:{item_id:"49c9ff66523870321fb8b116a51460f5",item_type:n,item_name:x,rec_info:ai}},{display_text:y,query_text:y,trace_info:{item_id:"55d403530416b5c9f8169beccf9de4f5",item_type:n,item_name:y,rec_info:aj}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:L,data:{h1:a,h2:a},config:{display:c,txt_style:d,type:"1",display2:c,url:a}},request_config:[{source_type:ak,related_name:al}],puuid:U,tag:a,category:"custom",uuid:am}],global:{urp_static_data:[{name:al,value:{status_code:d,columns:[{type:f,index_name:an,key:an},{type:f,index_name:ao,key:ao},{type:f,index_name:ap,key:ap},{type:f,index_name:aq,key:aq},{type:f,index_name:ar,key:ar}],datas:[{send_text:w,item_type:n,rec_info:ah,display_text:w,rec_reason:a},{send_text:x,item_type:n,rec_info:ai,display_text:x,rec_reason:a},{send_text:y,item_type:n,rec_info:aj,display_text:y,rec_reason:a}],dataSize:ak,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:as,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:G,"min-height":"100%",position:at,height:G},isMaterial:c,id:as,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:d,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:V,componentUuid:am,script:[{name:au,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:V,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:V},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:G,position:at,height:G},isMaterial:b,_id:19,id:au,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:T,voice_txt:a,tracking_info:{},uuid:U},order:{is_auto:c,render_for:T,chart_type:"command",puuid:U}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1003,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:K,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:H,answer_chain_name:Y},is_deep_research:c,deep_thinking:c,create_time:1746699015994},is_last:b}],questionItem:{data:{qStr:g,encodeFlag:c,imageData:p,docsData:[],quoteData:p},tplType:"question"},events:av,agentId:a,param:{entity_info:{},add_info:{ori_question:g},event_list:av,client_ip:a,question:g,user_id:z,user_name:a,trace_id:i,session_id:i,source:o,input_type:$}}],userId:z,userName:a,startTime:J,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:p,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:d,traceTableData:p,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-did-p3-health-partners-revenue-and-expenses-trend-in-q4-2024-46627e\u002F",config:{_app:{basePath:aw,assetsPath:aw,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,0,"other\u002FopenAnswer","STR","How did P3 Health Partners' revenue and expenses trend in Q4 2024?",1,"5681d10a-4d3e-404a-ad7c-6221ac6036b9","intusstock","186","signal","P3 Health Partners","llm_generated","ths_ainvest_lite_web",null,"PIII.O",999,2001,"PIII","Date","abs_国际美股领域","What was P3 Health Partners' net income for Q4 2024?","What were P3 Health Partners' revenue figures for Q4 2024?","How does P3 Health Partners' Q4 2024 financial performance compare to analyst expectations?","dp14838633","progress\u002Fsearching_for",1000,"searching_for","rich_text","Total Revenue","Net Income","auto","agent","PIII Revenue, Expenses, Net Income in Q4 2024",1746699000229,"inspect stocks","title1","code","fixed_index","Ticker","Name","DOUBLE","USD","Total Expenses","aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","P3 Health Partners (PIII) experienced a significant revenue increase in Q4 2024, with total revenue reaching $370.69 million. However, the company also faced notable expenses, with total expenses amounting to $129.15 million for the quarter. The substantial revenue growth suggests a strong performance in generating income, despite the expenses, which indicates a healthy financial trend for the period.\n\n\n|code|Ticker|Name|Date|Total Revenue|Total Expenses|Net Income|market_code|\n|---|---|---|---|---|---|---|---|\n|PIII|PIII.O|P3 Health Partners|2024 Q1|3.88488E8||-4.9606E7|186|\n|PIII|PIII.O|P3 Health Partners|2024 Q2|3.79157E8||-2.8774E7|186|\n|PIII|PIII.O|P3 Health Partners|2024 Q3|3.62124E8||-1.0285E8|186|\n|PIII|PIII.O|P3 Health Partners|2024 Q4|3.70686E8||-1.29148E8|186|\n\n","select   stock_code,   total_revenue,   total_expenses,   net_income from   ustock_fin_data where   report_end_date = date('2024y4q')   and stock_code = 'PIII.O'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite","stock","P3 Health Partners (PIII) experienced a significant revenue increase in Q4 2024, with total revenue reaching $370.69 million. However, the company also faced notable expenses, with total expenses amounting to $129.15 million for the quarter. The substantial revenue growth suggests a strong performance in generating income, despite the expenses, which indicates a healthy financial trend for the period[^1]",".\n\n\n``` visual\n{\"uuid\":\"c4ff7e85-e7f9-4d6d-b2d9-923327e46619\"}\n```","result_page","bar3","PIII Total Revenue, Net Income","market_code","2+679_496_21_554+0+0+5681d10a-4d3e-404a-ad7c-6221ac6036b9+00bd65451ab48cbe683de371aa214ee7+llm_generated+aimeTagAnalysis+0+0.05216481536626816+1","2+679_496_21_554+0+0+5681d10a-4d3e-404a-ad7c-6221ac6036b9+49c9ff66523870321fb8b116a51460f5+llm_generated+aimeTagAnalysis+0+0.04096562787890434+2","2+679_496_21_554+0+0+5681d10a-4d3e-404a-ad7c-6221ac6036b9+55d403530416b5c9f8169beccf9de4f5+llm_generated+aimeTagAnalysis+0+0.0362568274140358+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>